Pharming Group Company Profile (NASDAQ:PHGUF)

About Pharming Group

Pharming Group logoPharming Group NV (Pharming) is a Netherlands-based biotechnology company. The Company operates through two business segments, including Recombinant proteins, and DNage. Pharming focuses on the development, production and commercialization of human therapeutic proteins to be used as innovative therapies. The Company's products are aimed at treatments for genetic disorders and surgical and traumatic bleeding. Pharming's technologies include novel transgenic platforms for the production of biopharmaceuticals, as well as technology and processes for the purification and formulation of these biopharmaceuticals. The Company's commercial partners are: Santarus, Sobi, MegaPharm, Eczacibasi, Transmedic and Hyupjin. The Company operates worldwide. In March 2014, it announced downsizing of the Dutch operations following from strategic re-emphasis on collaborative development efforts and out-sourcing of non-core activities.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: PHGUF
  • CUSIP:
Key Metrics:
  • Previous Close: $0.25
  • 50 Day Moving Average: $0.00
  • 200 Day Moving Average: $0.00
  • 52-Week Range: $0.17 - $0.35
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -12.50
  • P/E Growth: 0.00
  • Market Cap: $103.15M
Additional Links:

Analyst Ratings

Consensus Ratings for Pharming Group (NASDAQ:PHGUF) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Pharming Group (NASDAQ:PHGUF)
No equities research coverage for this company has been tracked by


Earnings History for Pharming Group (NASDAQ:PHGUF)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/5/2015$0.04$0.05ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Pharming Group (NASDAQ:PHGUF)
Current Year EPS Consensus Estimate: $-0.03 EPS
Next Year EPS Consensus Estimate: $-0.02 EPS


Dividend History for Pharming Group (NASDAQ:PHGUF)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Pharming Group (NASDAQ:PHGUF)
No insider trades for this company have been tracked by


Latest Headlines for Pharming Group (NASDAQ:PHGUF)
News IconEquities Research Analysts' Upgrades for October, 12th (AMBA, AMD, ANFI, ASHM, BRKS, CAT, CUDA, CXW, ECM ... - DailyQuint (NASDAQ:PHGUF) - October 13 at 10:26 AM logoBRIEF-Pharming Group 8-month product sales rise to 6.2 million euros (NASDAQ:PHGUF) - October 3 at 1:45 AM logoBRIEF-Pharming Group amends Ruconest distribution agreement with Sobi (NASDAQ:PHGUF) - July 14 at 2:01 AM logoPharming Group N.V. : quaterly earnings release (NASDAQ:PHGUF) - May 14 at 2:31 PM
News IconPHARMING GROUP NV LEID (OTCMKTS:PHGUF) Sellers Increased By 163.41% Their Shorts - B.O.D.Y Confidential (NASDAQ:PHGUF) - May 12 at 2:29 PM
News IconStock Analysts' Upgrades for May, 11th (AWR, CIU, CMO, DWSN, FAN, FIS, IVR, JAZZ, JSAIY, KGC) - Washington News Wire (NASDAQ:PHGUF) - May 11 at 2:34 PM
News IconPHARMING GROUP NV LEID (OTCMKTS:PHGUF) Shorted Shares Increased 163.41% After Market Selling - B.O.D.Y Confidential (NASDAQ:PHGUF) - May 7 at 2:06 PM logoPHARMING GROUP NV LEID (OTCMKTS:PHGUF) Sellers Covered 59.54% of Their Shorts - Clinton Financial (NASDAQ:PHGUF) - April 14 at 2:32 PM
News IconAnalysis and Pharming Group N.V. (PHGUF) Earnings Review - (NASDAQ:PHGUF) - March 2 at 12:49 PM logoAnalysis and Pharming Group NV (PHGUF) Earnings Review - Clinton Financial (NASDAQ:PHGUF) - February 24 at 12:50 PM logoA European Biotech Stock Basket For 2016 - Seeking Alpha (NASDAQ:PHGUF) - January 27 at 11:43 AM


Pharming Group (NASDAQ:PHGUF) Chart for Monday, October, 24, 2016

Last Updated on 10/24/2016 by Staff